Ecolab reported third-quarter results with reported sales of $4,694.8 million, up 13% year-over-year, and organic sales growth accelerating to 7%. Reported diluted earnings per share were $1.95, while adjusted diluted EPS rose 5% to $2.18. The company raised its full-year 2026 adjusted diluted EPS outlook to a range of $8.10 to $8.20, representing growth of 8% to 9%. Ecolab also provided fourth-quarter guidance, expecting reported sales growth of 12% to 14% and adjusted diluted EPS between $2.13 and $2.23. The company operates in the water, hygiene, and infection prevention solutions industry.
